(4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid

CAS: 852155-81-8

Ref. 3D-CJB15581

Produktinformation

• Name: (4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid
• Marke: Biosynth
• Beschreibung: (4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl) c arbamoyl]butanoic acid is a glp-1 analogue that may be used for the treatment of metabolic disorders. It has been shown to increase insulin production in response to glucose and also has site specific activity. The compound binds to insulin receptors, which leads to increased synthesis of intracellular insulin and activation of downstream signaling pathways. The analog has a neutral pH and is stable in biological fluids such as human serum or dogfish plasma.

Chemische Eigenschaften

• Molekulargewicht: 513.5 g/mol
• Formel: C₂₀H₃₁N₇O₉
• Reinheit: Min. 95%